Is Kailera Therapeutics a Buy After Its Sizzling IPO?
In the biotech sector, private companies are moving from the sidelines into the spotlight through initial public offerings (IPOs). One…
Tag: Kailera
Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO
Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized…